Medtronic plc announced a collaboration with Orchestra BioMed Holdings to develop and commercialize AVIM therapy.
3 reports, 2 independent
Updated Aug 1
Gone quiet
- Reports
- 3
- Developments
- 2
- Repetition
- 33%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Medtronic plc announced a collaboration with Orchestra BioMed Holdings to develop and commercialize AVIM therapy.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Pursuing AVIM Therapy opportunity with Medtronic.1 source
Medtronic partners with Orchestra BioMed Holdings for AVIM therapy development.1 source
Keep exploring
The entities involved
Coverage
Newest first; wire copies grouped- manilatimes.net
- GlobeNewswireOrchestra BioMed Presents New AVIM Therapy Clinical Data at HRX Demonstrating Substantial and Sustained Blood Pressure Reductions that are Reproducible Upon Reactivation Following Washout Results fro
- GlobeNewswireOrchestra BioMed Announces Publication of Clinical Data Demonstrating Favorable Blood Pressure and Hemodynamic Effects of AVIM Therapy in JACC: Clinical Electrophysiology Data from acute and chronic